Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-07-11
2006-07-11
Habte, Kahsay (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S117000, C546S118000, C546S113000, C544S276000, C544S277000, C544S254000, C544S281000, C544S282000, C544S279000, C544S262000, C544S236000, C544S256000, C544S080000, C544S278000, C544S257000
Reexamination Certificate
active
07074929
ABSTRACT:
This invention relates to novel compounds, compositions, and methods for the treatment of physiological disorders associated with an excess of neuropeptide Y. The novel compounds encompassed by the present invention are those of the formula II, IV, V, VII–IX and XI
REFERENCES:
patent: 5273608 (1993-12-01), Nath
patent: 5504094 (1996-04-01), Bruns, Jr. et al.
patent: 5664057 (1997-09-01), Crossman et al.
patent: 6372743 (2002-04-01), Darrow et al.
patent: 6506762 (2003-01-01), Horvath et al.
patent: 6566367 (2003-05-01), Bakthavatchalam et al.
patent: 6696445 (2004-02-01), Horvath et al.
patent: 2001/0031474 (2001-10-01), Kinrade et al.
patent: 2003/0069246 (2003-04-01), Darrow et al.
patent: 2003/0144290 (2003-07-01), Blum et al.
patent: 2004/0072847 (2004-04-01), Bakthavatchalam et al.
patent: 0239191 (1987-09-01), None
patent: 0729758 (1996-09-01), None
patent: 0778277 (1997-06-01), None
patent: 9413676 (1994-06-01), None
patent: 9413677 (1994-06-01), None
patent: 9510506 (1995-04-01), None
patent: 9533750 (1995-12-01), None
patent: 9534563 (1995-12-01), None
patent: 9635689 (1996-11-01), None
patent: 9714684 (1997-04-01), None
patent: 9729110 (1997-08-01), None
patent: 9733580 (1997-09-01), None
patent: 9735539 (1997-10-01), None
patent: 9744038 (1997-11-01), None
patent: 9803510 (1998-01-01), None
patent: 9808846 (1998-03-01), None
patent: 9808847 (1998-03-01), None
patent: 9829397 (1998-07-01), None
patent: 9835967 (1998-08-01), None
patent: 9842699 (1998-10-01), None
patent: 9842706 (1998-10-01), None
patent: 9845295 (1998-10-01), None
patent: 9847874 (1998-10-01), None
patent: 9847903 (1998-10-01), None
patent: 9912908 (1999-03-01), None
patent: 9938868 (1999-08-01), None
patent: 9940091 (1999-08-01), None
patent: WO01/23387 (2001-04-01), None
patent: WO01/23389 (2001-04-01), None
patent: WO01/55103 (2001-08-01), None
patent: WO02/48152 (2002-06-01), None
patent: WO03/104255 (2003-12-01), None
Beck, J.P., et al. “Purin-8-ones As Corticotropin-Releasing Hormone (CRH-R1) Receptor Antagonists”Bioorganic&Medicinal Chemistry Letters 9, p. 967-972, (1999).
Arvanitis, A.G., et al. “Non-peptide Corticotropin-Releasing Hormone Antagonists: Syntheses and Structure . . . and -triazines”J. Med. Chem., vol. 42, p. 805-818, (1999).
Hodge, C.N., et al. “Corticotropin-Releasing Hormone Receptor Antagonists: Framework Design and Synthesis . . . Studies”J. Med. Chem., vol. 42, p. 819-832, (1999).
Chorvat, R.J., et al. “Synthesis, Corticotropin-Releasing Factor Receptor Binding Affinity, and Pharmokinetic . . . pyridines”J. Med. Chem., vol. 42, p. 833-848, (1999).
Chen, Y.L., et al. “Synthesis and Oral Efficacy of a 4-(Butylethylamino)pyrrolo[2,3-d]pyrimidine: A Centrally . . . Antagonist”J. Med. Chem., vol. 40, p. 1749-1754, (1997).
Chen, C., et al. “Design and Synthesis of a Series of Non-Peptide High-Affinity Human Corticotropin-Releasing Factor1 Receptor Antagonists”J. Med. Chem., vol. 39, p. 4358-4360, (1996).
Oravcova, J., et al. “Drug-protein Binding Studies New Trends in Analytical and Experimental Methodology” Journal of Chromatography B, vol. 677, p. 1-28, (1996).
Chorvat et al. (Journal of Medicinal Chemistry, 1999, vol. 42, No. 5).
Chalmers (TiPS vol. 17, pp. 166-172 Apr. 1996).
Lyrer (Schweiz. Med. Wochenschr., vol. 124, #45, 2005-2012 1994).
Frampton (Drugs and Aging 7 (6) 480-503 (1995).
Carpino Philip A.
De Lombaert Stephane
Griffith David A.
Hodgetts Kevin J.
Horvath Raymond F.
Guterman Sonia K.
Habte Kahsay
Lawson & Weitzen, LLP
Neurogen Corp.
Pfizer Inc.
LandOfFree
Certain alkylene diamine-substituted heterocycles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Certain alkylene diamine-substituted heterocycles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Certain alkylene diamine-substituted heterocycles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3558483